Real-time enrollment status for this metastatic malignant neoplasm clinical trial
Current Status
Recruiting
Checked: September 8, 2026 at 8:05 PM UTC
| NCT Number | NCT07563829 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Malignant Neoplasm |
| Phase | PHASE1 |
| Target Enrollment | 81 participants |
| Active Locations | 6 sites in the US |
| Sponsor | NextPoint Therapeutics, Inc. |
| Last Updated on CT.gov | September 8, 2026 (20 hours ago) |
As of September 8, 2026: Clinical trial NCT07563829 is currently recruiting participants. This phase1 study for metastatic malignant neoplasm is actively seeking new participants at 6 locations across the United States. The study is sponsored by NextPoint Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07563829 is actively recruiting participants as of September 8, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07563829 was last updated 20 hours ago (September 8, 2026). HelloStudys verifies this status automatically.